NVO 241206 90.00P (NVO241206P90000) Stock Options, News & Quotes

US OptionsDetailed Quotes

NVO241206P90000

Watchlist

0.11
-0.02-15.38%

15min DelayClose Nov 29 13:00 ET

0.11High0.09Low

Intraday

5D
Daily

News

Why Is Novo Nordisk A/S (NVO) Among Louis Navellier's Top Stock Picks Heading Into 2025?
Yahoo Finance14:42 ET
Novo Nordisk A/S (NVO): A Bull Case Theory
Yahoo FinanceNov 30 14:42 ET
What the Options Market Tells Us About Novo Nordisk
BenzingaNov 29 10:16 ET
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
BenzingaNov 29 08:42 ET
Aurisco Pharmaceutical (605116.SH): Currently, there is no collaboration with Novo-Nordisk A/S.
On November 28, Glonghui reported that aurisco pharmaceutical (605116.SH) stated on the investor interaction platform that the company is actively developing the market for the active pharmaceutical ingredient semaglutide, and currently has no collaboration with novo-nordisk a/s.
Gelonghui FinanceNov 28 04:39 ET
Sector Update: Health Care Stocks Advance Wednesday Afternoon
MT NewswiresNov 27 13:42 ET

Comments

Money Thrill

Nov 27 10:32

European Morning News but now in evening here 😅

$Novo-Nordisk A/S (NVO.US)$ The European Commission has authorized the acquisition of joint control of ... "Sylvan International Biotechnology" ... , from China, by Novo Nordisk Foundation, from Denmark, and KKR, from the United States. The operation mainly concerns the development and of the production of edible mushroom mycelium.
The Commission concluded that the notified transaction would not raise competition concerns, given that the joint ventu...

Ho Lee Fuk

Nov 26 08:53

$Novo-Nordisk A/S (NVO.US)$ up idiot

Movers and Shakers

Nov 26 07:03

Columns Today's Pre-Market Movers and Top Ratings | PSTX, LLY, KSS, BBY and More

Morning Movers
Gapping up
$Poseida Therapeutics (PSTX.US)$' stock jumped over 200%. This happened because Roche, a Swiss company, is buying Poseida for up to $1.5 billion in cash.
Shares of weight-loss drug maker $Novo-Nordisk A/S (NVO.US)$ and $Eli Lilly and Co (LLY.US)$ rose 2.1% and 4.9% respectively on Tuesday as U.S. President Jo Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid...

MonkeyGee

Nov 26 06:48

watch for the rug pull. if you can't tell when there is a flood of news, it's driven by AI to pump the stock. guess which week they pick to do this in, and you can guess what's going to happen next week.

"Norel" welcomes a heavyweight bullish news! It is rumored that weight loss drugs are expected to enter the US medical insurance system.

WagyuInvester636

Nov 26 04:57

$NVO 250221 110.00C$ call more tonight haha